Stocklytics Platform
Asset logo for symbol MDGL
Madrigal Pharmaceuticals
MDGL49
$233.39arrow_drop_down3.47%-$8.41
Asset logo for symbol MDGL
MDGL49

$233.39

arrow_drop_down3.47%

AI Deep-Learning Forecast (MDGL)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Madrigal Pharmaceuticals (MDGL) Stocklytics Forecast

According to the stock price prediction for Madrigal Pharmaceuticals Inc (MDGL), analysts forecast a positive future for the company. With its innovative drug pipeline and promising clinical trial results, MDGL is expected to achieve significant growth in the coming years. The AI-powered prediction models also suggest a bullish trend for MDGL, indicating potential gains for investors. Machine learning algorithms have analyzed various factors such as historical data, market trends, and company performance to generate accurate forecasts for MDGL.
Based on the latest price target estimates, analysts anticipate a substantial increase in MDGL's stock value by 2023. The projected price target indicates a positive outlook for the company, reflecting optimistic expectations from the market. Investors should consider these expert recommendations and price targets before making investment decisions regarding MDGL. It is worth noting that the analyst ratings for MDGL have also been positive, further adding to the potential attractiveness of the stock. With the combination of favorable forecasts, price targets, and analyst ratings, MDGL appears to be a good buy for investors seeking growth opportunities.
add Madrigal Pharmaceuticals  to watchlist

Keep an eye on Madrigal Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Madrigal Pharmaceuticals (MDGL) stock?

Analysts have set a target price of $327.41 for Madrigal Pharmaceuticals (MDGL), based on forecasts from 29 analysts. The predicted price range extends from a high of $425 to a low of $150. This represents a potential increase of up to 82.1% and a decrease of -35.73% from the current price of $233.39. These forecasts are as of 2023 Sep 12.
help

What are the analyst ratings for Madrigal Pharmaceuticals (MDGL) stock?

The analyst ratings for Madrigal Pharmaceuticals (MDGL) are distributed as follows: 3 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Madrigal Pharmaceuticals .
help

What is the AI price prediction for Madrigal Pharmaceuticals (MDGL) stock?

The AI price prediction model, leveraging machine-learning techniques, forecasts that Madrigal Pharmaceuticals (MDGL) stock could reach $247.68 by 2024 Sep 30. This prediction indicates a potential price change of 6.12%. The forecast has a lifetime of 30 days, culminating on the target date provided. The prediction was made on 2024 Sep 09.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media